Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
NCT02253654
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
216
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Insufficiency, Chronic
Anemia
Renal Dialysis
Erythrocyte Transfusion
Interventions
DRUG:
Epoetin alfa
Sponsor
Amgen